临床试验/NCT00000340

NCT00000340撤回2 期

Pemoline in the Treatment of Stimulant Dependence

National Institute on Drug Abuse (NIDA)0 个研究点开始时间: 1996年6月最近更新: 2017年1月12日

适应症

试验速览

阶段: 2 期
状态: 撤回
发起方: National Institute on Drug Abuse (NIDA)
主要终点: Retention

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).

研究设计

研究类型: Interventional
主要目的: Treatment

入排标准

年龄范围: 21 Years 至 50 Years（Adult）
性别: All
接受健康志愿者: 否

入选标准

•M/F ages 21-
•Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent.

排除标准

•Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.

结局指标

主要结局

Retention

Depression

Incidence of stimulant use

Severity of stimulant withdrawal symptoms

ADHD symptom severity

Degree of drug craving

Frequency of IV drug use and sexual risk behaviors

次要结局

未报告次要终点

研究者

发起方

National Institute on Drug Abuse (NIDA)

申办方类型

Nih

相似试验

已完成

2 期

Pemoline for Cocaine Abuse - 7Cocaine-Related Disorders

NCT00000282Yale University

已完成

2 期

Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5Cocaine-Related DisordersSubstance-Related Disorders

NCT00015223National Institute on Drug Abuse (NIDA)

已完成

3 期

Citicoline Treatment of Methamphetamine DependenceMethamphetamine Dependence

NCT00950352Perry Renshaw104

已完成

1 期

Pharmacotherapy & CM for Opioid and Cocaine DependenceCocaine Dependence

NCT00838981Yale University91

已完成

4 期

Brain Changes in Stimulant Dependent Subjects - 8Substance-Related Disorders

NCT00000343National Institute on Drug Abuse (NIDA)90